✦ LIBER ✦

The use of flutamide in hormone-refractory metastatic prostate cancer

✍ Scribed by D. G. McLeod; R. C. Benson Jr; M. A. Eisenberger; E. D. Crawford; B. A. Blumenstein; D. Spicer; J. T. Spaulding

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 444 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931215)72:12+<3870::aid-cncr2820721721>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral etoposide in the treatment of hormo

Oral etoposide in the treatment of hormone-refractory prostate cancer

✍ Maha H. Hussain; Kenneth J. Pienta; Bruce G. Redman; Glenn D. Cummings; Lawrence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 1 views

Fibrinolysis in metastatic cancer of the

Fibrinolysis in metastatic cancer of the prostate

✍ Henry J. Tagnon; Willet F. Whitmore Jr.; N. Raphael Shulman 📂 Article 📅 1952 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 2 views

Circulating levels of interleukin-6 in p

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

✍ Drachenberg, Darrel E.; Elgamal, Abdel-Aziz A.; Rowbotham, Ron; Peterson, Mary; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 1 views

BACKGROUND. ) is a cytokine that plays a central role in host defense due to its wide range of immune and hematopoietic activities. It is found in high levels in human ejaculate, and has recently been found to regulate prostate-specific protein expression in prostate cancer cells through nonsteroida

Chemotherapy for hormone-refractory pros

Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

✍ Tomasz Beer; Derek Raghavan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Higher-dose and less frequent dendritic

Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients

✍ Murphy, G.P.; Tjoa, B.A.; Simmons, S.J.; Rogers, M.K.; Kenny, G.M.; Jarisch, J. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

## BACKGROUND. Infusion of dendritic cells (DCs) pulsed with PSMA peptides was considered possible in hormone-refractory metastatic prostate cancer patients both with or without prior treatment with a greater number of DCs and for lesser infusions than previously administered. METHODS. DCs + PSMA p

A phase II study of recombinant human al

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer

✍ Carol M. Van Haelst-Pisani; Ronald L. Richardson; John Su; Jan C. Buckner; Richa 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

To determine the efficacy of recombinant human leukocyte alpha-interferon (IFL-RA) in advanced hormone-refractory prostate cancer, the authors treated 40 patients with IFL-RA administered intramuscularly at a dose of 10 x 10' U/m2 three times weekly. Toxicity was substantial and necessitated at leas